DE60317639D1 - Zusammensetzungen enthaltend n-acyl-phosphatidyl-ethanolamin und/oder mischungen von n-acyl-ethanolaminen mit phosphatidinsäuren oder lysophosphatidinsäuren - Google Patents

Zusammensetzungen enthaltend n-acyl-phosphatidyl-ethanolamin und/oder mischungen von n-acyl-ethanolaminen mit phosphatidinsäuren oder lysophosphatidinsäuren

Info

Publication number
DE60317639D1
DE60317639D1 DE60317639T DE60317639T DE60317639D1 DE 60317639 D1 DE60317639 D1 DE 60317639D1 DE 60317639 T DE60317639 T DE 60317639T DE 60317639 T DE60317639 T DE 60317639T DE 60317639 D1 DE60317639 D1 DE 60317639D1
Authority
DE
Germany
Prior art keywords
acyl
acids
phosphatidinic
lysophosphatidinic
ethanolamines
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60317639T
Other languages
English (en)
Other versions
DE60317639T3 (de
DE60317639T2 (de
Inventor
Elvira Pistolesi
Benvenuto Cestaro
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hunza Di Pistolesi Elvira & C
Original Assignee
Hunza Di Pistolesi Elvira & C
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27736279&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE60317639(D1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from IT2002MI000270A external-priority patent/ITMI20020270A1/it
Priority claimed from ITMI20022512 external-priority patent/ITMI20022512A1/it
Application filed by Hunza Di Pistolesi Elvira & C filed Critical Hunza Di Pistolesi Elvira & C
Publication of DE60317639D1 publication Critical patent/DE60317639D1/de
Application granted granted Critical
Publication of DE60317639T2 publication Critical patent/DE60317639T2/de
Publication of DE60317639T3 publication Critical patent/DE60317639T3/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/661—Phosphorus acids or esters thereof not having P—C bonds, e.g. fosfosal, dichlorvos, malathion or mevinphos
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23J—PROTEIN COMPOSITIONS FOR FOODSTUFFS; WORKING-UP PROTEINS FOR FOODSTUFFS; PHOSPHATIDE COMPOSITIONS FOR FOODSTUFFS
    • A23J7/00—Phosphatide compositions for foodstuffs, e.g. lecithin
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/164—Amides, e.g. hydroxamic acids of a carboxylic acid with an aminoalcohol, e.g. ceramides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A61K31/366—Lactones having six-membered rings, e.g. delta-lactones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/55—Phosphorus compounds
    • A61K8/553—Phospholipids, e.g. lecithin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/08—Drugs for disorders of the urinary system of the prostate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/14—Drugs for dermatological disorders for baldness or alopecia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/16—Emollients or protectives, e.g. against radiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/06—Preparations for care of the skin for countering cellulitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Biochemistry (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Mycology (AREA)
  • Birds (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Nutrition Science (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Psychiatry (AREA)
  • Rheumatology (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Reproductive Health (AREA)
  • Psychology (AREA)
  • Toxicology (AREA)
DE60317639T 2002-02-12 2003-02-07 Zusammensetzungen enthaltend n-acyl-phosphatidyl-ethanolamin und/oder mischungen von n-acyl-ethanolaminen mit phosphatidinsäuren oder lysophosphatidinsäuren Expired - Lifetime DE60317639T3 (de)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
IT2002MI000270A ITMI20020270A1 (it) 2002-02-12 2002-02-12 Preparazione nutrizionali e terapeutiche a base di n-acil-fosfatidil-etanolamine e/o miscele di n-acil-etanolamine con acidi fosfatidici o a
ITMI20020270 2002-02-12
ITMI20022512 2002-11-26
ITMI20022512 ITMI20022512A1 (it) 2002-11-26 2002-11-26 Preparati a base di n-acil-fosfatidil-etanolamine e/o miscele di n-acil-etanolamine con acidi fosfatidici o acidi liso-fosfatidici.
EP03739457A EP1482920B2 (de) 2002-02-12 2003-02-07 Zusammensetzungen enthaltend n-acyl-phosphatidyl-ethanolamin und/oder mischungen von n-acyl-ethanolaminen mit phosphatidinsäuren oder lysophosphatidinsäuren
PCT/EP2003/001233 WO2003068210A1 (en) 2002-02-12 2003-02-07 N-acyl-phosphatidyl-ethanolamines and/or mixtures of n-acyl-ethanolamines with phosphatidic acids or lysophosphatidic acids

Publications (3)

Publication Number Publication Date
DE60317639D1 true DE60317639D1 (de) 2008-01-03
DE60317639T2 DE60317639T2 (de) 2008-10-30
DE60317639T3 DE60317639T3 (de) 2012-01-12

Family

ID=27736279

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60317639T Expired - Lifetime DE60317639T3 (de) 2002-02-12 2003-02-07 Zusammensetzungen enthaltend n-acyl-phosphatidyl-ethanolamin und/oder mischungen von n-acyl-ethanolaminen mit phosphatidinsäuren oder lysophosphatidinsäuren

Country Status (8)

Country Link
US (2) US20050118232A1 (de)
EP (1) EP1482920B2 (de)
JP (1) JP4634040B2 (de)
AU (1) AU2003226974A1 (de)
CA (1) CA2475630C (de)
DE (1) DE60317639T3 (de)
ES (1) ES2297176T5 (de)
WO (1) WO2003068210A1 (de)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ITMI20021280A1 (it) * 2002-06-11 2003-12-11 Carlo Ghisalberti Metodo di trattamento anticellulite
ITMI20041280A1 (it) * 2004-06-24 2004-09-24 Hunza Di Pistolesi Elvira & C Preparazione farmaceutiche dietetiche e-o cosmetiche per il trattamento dell'obesita' dell'alopecia della cellulite e dell'invecchiamento cutaneo
DE102004052697A1 (de) * 2004-10-29 2006-05-04 Haehner, Thomas, Dr. Pharmazeutische Zubereitungen zur Behandlung von Folgen des Alkoholmissbrauchs, Hepatitis, Pankreatitis, Alzheimererkrankung, Morbus Parkinson, Diabetes, toxischen Nierenerkrankungen, Reperfusionsschäden, der Arteriosklerose sowie als Antidote gegen Umweltgifte und Medikamentenintoxikation
EP1844785A1 (de) * 2006-04-13 2007-10-17 Indena S.P.A. Phospholipidkomplexe der Extrakte aus Oliven und Olivenblättern mit verbesserter Bioverfügbarkeit
JP2007314427A (ja) * 2006-05-23 2007-12-06 Nippon Fine Chem Co Ltd リポ酸含有複合体
JP5259601B2 (ja) * 2007-08-28 2013-08-07 ユニチカ株式会社 コラーゲン産生促進剤
EP2107097B1 (de) 2008-04-02 2011-06-15 Nestec S.A. Funktionelle Mesophasen auf Oleylethanolamidbasis
WO2010004597A1 (en) 2008-07-08 2010-01-14 Chemi Spa Rocess for the production of n-acyl-phosphatidyl-etanolamine
JP2010189315A (ja) * 2009-02-18 2010-09-02 Unitika Ltd 関節軟骨損傷治癒促進剤及びそれを含有する飲食品
JP2010195752A (ja) * 2009-02-27 2010-09-09 Unitika Ltd 骨形成促進剤
WO2012143860A1 (en) * 2011-04-18 2012-10-26 Jian Guan Ameliorating cognitive decline
CN104768966B (zh) * 2012-09-24 2018-11-02 中化帝斯曼制药有限公司荷兰公司 生产环肽的方法
WO2016016790A1 (en) * 2014-07-31 2016-02-04 Universita' Degli Studi Di Cagliari Ester of a phospholipid with conjugated linoleic acid for the treatment of psychiatric disorders with neuroinflammatory and neurodegenerative basis
JP6953811B2 (ja) * 2017-06-12 2021-10-27 ライオン株式会社 口腔用組成物及び口腔内常在菌の生育促進剤
EP3707513B1 (de) 2017-11-07 2024-02-07 Fondazione Istituto Italiano di Tecnologia Verfahren zur feststellung des vorliegens und fortschreitens einer neurodegenerativen erkrankung
JP7255205B2 (ja) * 2019-01-30 2023-04-11 セイコーエプソン株式会社 ロボットシステムおよびロボット制御装置
IT202100018455A1 (it) 2021-07-13 2023-01-13 Fondazione St Italiano Tecnologia Biomarcatori della malattia di alzheimer

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR972927A (fr) 1947-05-14 1951-02-05 Brillantine aux phosphatides (lécithines et céphalines) du soja
US4254115A (en) * 1979-06-18 1981-03-03 A. Nattermann & Cie. Gmbh Phospholipid derivative with an antilipemic and antiarteriosclerotic effect
GB2051069B (en) 1979-06-18 1983-08-24 Nattermann A & Cie Phospholipid derivatives useful in therapy as antilepaemics and antiarteriosclerotics and compositions containing them
DE3109420A1 (de) 1981-03-12 1982-09-23 Kastell, Wolfgang, 2000 Hamburg Mittel zum anhalten des haarausfalls und zum foerdern des haarwuchses
EP0122151B1 (de) 1983-04-11 1989-02-15 Meito Sangyo Kabushiki Kaisha Herstellung von primären oder sekundären Phospholipid-Alkohol-Derivaten durch enzymatische Technik
IT1201151B (it) † 1987-01-14 1989-01-27 Indena Spa Complessi fosfolipidici con estratti da vitis vinifera,procedimento per la loro preparazione e composizioni che li cntengono
IT1201149B (it) * 1987-01-14 1989-01-27 Indena Spa Complessi di bioflavonoidi con fosfolipidi,loro preparazione,uso e composizioni farmaceutici e cosmetiche
US5741513A (en) * 1990-02-08 1998-04-21 A. Natterman & Cie. Gmbh Alcoholic aqueous gel-like phospholipid composition, its use and topical preparations containing it
EP0620000A3 (de) 1992-12-18 1994-11-02 Rhone-Poulenc Rorer Gmbh Kosmetische und/oder pharmazeutische Verwendung von N-Acylalkanolaminen
EP0604806A3 (de) 1992-12-18 2000-07-19 Rhone-Poulenc Rorer Gmbh Phospholipidische Zusammensetzung
FR2724394B1 (fr) * 1994-09-13 1997-01-10 Agronomique Inst Nat Rech Procede d'obtention d'acide vanillique et de vanilline par bioconversion par une association de microorganismes filamenteux
JPH1084880A (ja) * 1996-09-13 1998-04-07 Takeda Shokuhin Kogyo Kk 脂質代謝促進作用を有するリン脂質含有組成物
ES2321769T3 (es) * 1996-10-15 2009-06-10 Transave, Inc. Liposomas de n-acil fosfatidiletanolamina para el transporte de medicamentos.
US6454871B1 (en) * 1997-06-23 2002-09-24 Princeton Trade & Technology, Inc. Method of cleaning passageways using a mixed phase flow of gas and a liquid
US20010055627A1 (en) * 1997-09-26 2001-12-27 Najla Guthrie Compositions And Methods For Regulating Lipoproteins And Hypercholesterolemia With Limonoids, Flavonoids And Tocotrienols
JP4738592B2 (ja) * 1997-10-31 2011-08-03 アーチ・デヴェロップメント・コーポレイション ５α−還元酵素活性を調節するための方法及び組成物
JP3153505B2 (ja) * 1997-11-07 2001-04-09 矢橋工業株式会社 水酸アパタイトファイバーの製造方法
JP2000095792A (ja) * 1998-09-21 2000-04-04 Showa Sangyo Co Ltd ゲニスチンから成るイソフラボン組成物の取得方法
IT1304183B1 (it) * 1998-12-18 2001-03-08 Indena Spa Complessi di proantocianidina a2 con fosfolipidi come agentiantiaterosclerotici.
JP2000219880A (ja) * 1999-01-29 2000-08-08 Taiyo Kagaku Co Ltd 抗酸化剤
US6610749B2 (en) * 2000-02-18 2003-08-26 Arch Development Corporation Polyhydroxylated benzene-containing compounds
IL158131A0 (en) † 2001-03-27 2004-03-28 Univ California Methods, compounds, and compositions for reducing body fat and modulating fatty acid metabolism
MY135783A (en) * 2001-09-07 2008-06-30 Meiji Dairies Corp Nutritional composition for controlling blood sugar level
DE102007049867A1 (de) 2007-10-18 2009-04-30 Abb Ag Paramagnetischer Gassensor sowie Verfahren zum Betrieb desselben
US8232418B1 (en) * 2008-08-01 2012-07-31 Corn Products International, Inc. Method for the preparation of lecithin
SG174891A1 (en) * 2009-04-01 2011-11-28 Genentech Inc Treatment of insulin-resistant disorders
US8974818B2 (en) * 2010-01-20 2015-03-10 Henry Wu Custom-formulated phospholipid microbubbles and methods and uses thereof

Also Published As

Publication number Publication date
JP2005525335A (ja) 2005-08-25
DE60317639T3 (de) 2012-01-12
EP1482920B2 (de) 2011-07-20
EP1482920A1 (de) 2004-12-08
US20050118232A1 (en) 2005-06-02
AU2003226974A1 (en) 2003-09-04
EP1482920B1 (de) 2007-11-21
JP4634040B2 (ja) 2011-02-16
CA2475630C (en) 2011-01-18
WO2003068210A1 (en) 2003-08-21
DE60317639T2 (de) 2008-10-30
ES2297176T5 (es) 2011-12-07
US9789127B2 (en) 2017-10-17
CA2475630A1 (en) 2003-08-21
ES2297176T3 (es) 2008-05-01
US20100179107A1 (en) 2010-07-15

Similar Documents

Publication Publication Date Title
DE60317639D1 (de) Zusammensetzungen enthaltend n-acyl-phosphatidyl-ethanolamin und/oder mischungen von n-acyl-ethanolaminen mit phosphatidinsäuren oder lysophosphatidinsäuren
ATE410175T1 (de) Co-perlchen von dha und rosmarin
DE60238576D1 (de) Zusammensetzung zur Herstellung von Elektroden und Elektroden
ATE465712T1 (de) Ultrafeine zusammensetzungen von formoterol
DE60222671D1 (de) Thienopyrimidinedione und deren verwendung in der behandlung von autoimmunerkrankungen
AR028027A1 (es) Componente de compuestos en secciones y procedimiento para producir el mismo
DE60326611D1 (de) N und dergleichen
DE60335282D1 (de) Polycarbonatharzzusammensetzung und formkörper daraus
DE60317699D1 (de) Fermentationsverfahren und -zusammensetzungen
DE60327203D1 (de) Kombination von azelastine und fluticasone
DE60216254D1 (de) Acrylkautschukzusammensetzung und vulkanisat
ATE398445T1 (de) Co-perlchen von dha und rosmarin und verwendungsverfahren
DE60334131D1 (de) Acrylkautschukzusammensetzung und vernetztes objekt
DE60333629D1 (de) Neue phospholipasen und deren verwendungen
ATE539746T1 (de) Zusammensetzung zur verbesserung von kognition und gedächtnis
DE60330255D1 (de) Thermoplastharzzusammensetzung und formkörper daraus
DE60336720D1 (de) Fluorsulfate von hexafluorisobutylen und dessen höheren homologen und deren derivaten
ATE357245T1 (de) Biologisch stabile flüssige zusammensetzung von fviii, vwf oder fviii/vwf-komplex menschlichen ursprungs
ATE423558T1 (de) Verwendung von alpha-phenylthiokarbonsäuren mit serumglucose- und serumlipid-senkender wirkung
DE60305081D1 (de) Fluorkautschukzusammensetzung und Gegenstand
ATE399076T1 (de) Herstellung und verwendung von mehrkarbidmaterialien
DE60215392D1 (de) Gerät mit reduzierten abmessungen und verbesserter ergonomie zur behandlung der oberfläche von objekten
DE50308856D1 (de) Verringerung des kontaktwiderstandes in organischen feldeffekttransistoren durch verwendung von phosphinen und metallhaltigen phosphinen
DE60318819D1 (de) Hitzestabile mutanten von stärkebiosyntheseenzymen
DE60309255D1 (de) Abbildung und Entnahme von Gel

Legal Events

Date Code Title Description
8363 Opposition against the patent
R102 Epo decision maintaining patent in amended form now final

Ref document number: 1482920

Country of ref document: EP

R102 Epo decision maintaining patent in amended form now final

Ref document number: 1482920

Country of ref document: EP

Effective date: 20110720